In his extensive financial management career, Tim has provided financial consulting services to multiple publicly held and private-equity-backed life sciences companies, and he has held several senior financial management roles, primarily in software and technology services. Tim is a noted expert in forensic accounting and internal audit. He has served as the internal auditor hired by public company audit committees on several occasions.

In 2018, he was engaged by Milestone Pharmaceuticals to prepare and lead its IPO. Before that, Tim served as the CFO of Ballantyne Therapeutics. Earlier, during his eight years as the Senior Director of Finance and Corporate Controller at Chelsea Therapeutics International, he was heavily involved in Chelsea’s reverse-public-shell merger to complete its public listing in 2005.

Tim received a B.S. in accounting from the University of North Carolina at Charlotte, and he is licensed as a Certified Public Accountant and as a Chartered Global Management Accountant.